APC's joint comment letter with NCPA regarding HHS' interim peptide policy
Read APC's joint comment letter with the National Community Pharmacists Association regarding HHS' interim peptide policy
Being an exceptional compounding professional means you never stop learning
We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
Read APC's joint comment letter with the National Community Pharmacists Association regarding HHS' interim peptide policy
States are responding differently to HHS’s peptide policy. Where Utah, Arizona, Massachusetts, and Illinois stand, and what 2027 bills could mean.
Legislators call people they know. See how Innovation Compounding hosted Georgia Sen. Kay Kirkpatrick for a pharmacy tour, and why you should, too.
APC board member Matt Johnson explains why a peptide certificate of analysis may not meet HHS’s new policy and how to verify supplier claims.
APC members: ScriptSafe can cut the time and cost of online payment certification, and one member found $160,000 in annual savings with APC Payments. ...
Unapproved obesity drug spawns a black market frenzy